Recent Posts
- Novel Hydrogen transport and storage technology developer HySilabs raises 13€ million in its series A
- Amolyt Pharma annonces research agreement and licensing option with XOMA
- Amolyt Pharma announces $ 138 Million Series C Financing led by Sofinnova Partners and co-led by Intermediate Capital Group
- OREGA Biotech enters into an Exclusive License Agreement with Genmab for a novel immuno-oncology antibody program
- Amolyt Pharma Announces Positive Safety and Efficacy Results from Second Patient Cohort in its Phase 2a Trial of AZP-3601 for the Treatment of Hypoparathyroidism
Archives
- January 2023
- December 2022
- October 2022
- September 2022
- August 2022
- June 2022
- May 2022
- April 2022
- March 2022
- February 2022
- October 2021
- September 2021
- August 2021
- July 2021
- May 2021
- April 2021
- March 2021
- January 2021
- December 2020
- November 2020
- October 2020
- September 2020
- July 2020
- April 2020
- January 2020
- December 2019
- November 2019
- October 2019
- September 2019
- July 2019
- March 2019
- February 2019
- December 2018
- November 2018
- December 2017
- September 2017
- April 2017